All
My Oncologist Gave Me a Pseudo-Medication Taper That Made Me Feel Like I Was Losing Control
February 16th 2022In the midst of my treatment for mantle cell lymphoma, I had to suffer through the feeling of wanting to crawl out of my own skin when my oncologist gave me a medication tapering plan that was not gradual enough.
Patients With Kidney Cancer ‘Continue to See Benefit’ With Post-Surgical Keytruda
February 16th 2022At a 30-month follow-up, patients with renal cell carcinoma — which is the most common type of kidney cancer — who underwent nephrectomy continued to benefit from Keytruda after the surgical removal of the affected kidney.
As More and More People Become Tethered to Their Cell Phones, I Worry About Radiation Causing Cancer
February 15th 2022Many young people slip cell phones inside their bras or pockets without a thought, but I worry if that is a safe practice and wonder if it could lead to health problems — such as cancer — in the future.
Eating After My Cancer Treatment Was So Painful, It Felt Like I Had Strep Throat for 1 Year
February 15th 2022After realizing that alcohol and spicy foods were excruciating to consume after treatment, throat cancer survivor Rob Paulsen learned that smoothies were a much healthier — and more soothing — option.
Advancements in Rare Blood Cancer Have ‘Changed the Way We Treat Every Cancer’, Expert Says
February 11th 2022A blood cancer specialist discusses how the development of tyrosine kinase inhibitors in the 1990s to treat chronic myelogenous leukemia drove major oncology advancements over the next three decades.
Losing His Wife to Cancer Brought Chris Draft From the NFL to the White House
February 10th 2022On this episode of the “Cancer Horizons” podcast, former NFL linebacker Chris Draft discusses his wife’s experience with cancer, which led to her untimely death, and describes why advocacy is so important in the cancer world, especially with Cancer Moonshot bringing disparities to the forefront.
Clinical Trial Testing Effectiveness of LOXO-305 in Mantle Cell Lymphoma Now Open to Patients
February 9th 2022A phase 3 trial evaluating the safety and efficacy of the BTK inhibitor LOXO-305 in patients with previously treated mantle cell lymphoma is now open to patients across more than a dozen states.
Biden’s Cancer Moonshot Will ‘Reenergize Fight Against Cancer,’ Expert Says
February 9th 2022As the number of cancer diagnoses continues to rise in the United States, the relaunch of President Joe Biden’s Cancer Moonshot is needed now more than ever, explained an expert at Hackensack Meridian John Theurer Cancer Center.